eFFECTOR Therapeutics Raises $40 Million Series B Financing
SAN DIEGO, December 22, 2015 – eFFECTOR Therapeutics, a biopharmaceutical company developing translation regulators for the treatment of...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page